<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d141" origId="Aminohippurate"><sentence id="DrugDDI.d141.s0" origId="s0" text="Renal clearance measurements of PAH cannot be made with any significant accuracy in patients receiving sulfonamides, procaine, or thiazolesulfone."><entity charOffset="103-115" id="DrugDDI.d141.s0.e0" origId="s0.p8" text="sulfonamides" type="drug"/><entity charOffset="117-125" id="DrugDDI.d141.s0.e1" origId="s0.p9" text="procaine" type="drug"/><pair e1="DrugDDI.d141.s0.e0" e2="DrugDDI.d141.s0.e1" id="DrugDDI.d141.s0.p0" interaction="false"/><negationtags>&lt;xcope&gt; Renal clearance measurements of PAH &lt;cue&gt;cannot&lt;/cue&gt; be made &lt;/xcope&gt; with any significant accuracy in patients receiving sulfonamides, procaine, or thiazolesulfone.</negationtags></sentence><sentence id="DrugDDI.d141.s1" origId="s1" text="These compounds interfere with chemical color development essential to the analytical procedures."/><sentence id="DrugDDI.d141.s2" origId="s2" text="Probenecid depresses tubular secretion of certain weak acids such as PAH."><entity charOffset="0-10" id="DrugDDI.d141.s2.e0" origId="s2.p16" text="Probenecid" type="drug"/></sentence><sentence id="DrugDDI.d141.s3" origId="s3" text="Therefore, patients receiving probenecid will have erroneously low ERPF and Tm PAH values."><entity charOffset="30-40" id="DrugDDI.d141.s3.e0" origId="s3.p24" text="probenecid" type="drug"/></sentence></document>